Leading Pharmacy, Advancing Healthcare
Educate - Advocate - Empower - Engage
The Oregon Board of Pharmacy held a regularly scheduled meeting in October 2023. One of the agenda items was a formal request from OSPA to repeal rule 855-115-0150 for Prohibited Practices, that state a “Pharmacist Must Not: Diagnose.”
Below is a copy of the letter we submitted to the Board of Pharmacy. We encourage all pharmacists to read this letter and provide public comment during the Board meeting in December 2023.
We have heard from strong pharmacies who have prepared for the DIR cliff, have cash flow addressed, already diversified revenue and maximize other opportunities that without action by CMS to pressure the plans for ‘reasonable and relevant’ contract terms there will be massive pharmacy closures. While the advocacy to pass bipartisan PBM legislation is important – something needs to be done immediately to address the 2024 Part D contracts. Below is a copy of the email that was sent to Senator Wyden’s Medicaid Advisor.
Read OSPA’s response to HB 3013 not passing in the 2023 legislative session and the next steps we are taking to address PBM reform.
Save the date!
March 2-3, 2024
The Graduate Hotel – Eugene